Bioptik Technology (Taiwan) Performance
| 4161 Stock | TWD 26.55 0.15 0.56% |
The firm shows a Beta (market volatility) of -0.0932, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Bioptik Technology are expected to decrease at a much lower rate. During the bear market, Bioptik Technology is likely to outperform the market. At this point, Bioptik Technology has a negative expected return of -0.0466%. Please make sure to confirm Bioptik Technology's jensen alpha, treynor ratio, and the relationship between the information ratio and total risk alpha , to decide if Bioptik Technology performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Bioptik Technology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Bioptik Technology is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors. ...more
| Begin Period Cash Flow | 258 M | |
| Total Cashflows From Investing Activities | -118.6 M |
Bioptik |
Bioptik Technology Relative Risk vs. Return Landscape
If you would invest 2,750 in Bioptik Technology on October 23, 2025 and sell it today you would lose (95.00) from holding Bioptik Technology or give up 3.45% of portfolio value over 90 days. Bioptik Technology is generating negative expected returns and assumes 1.5062% volatility on return distribution over the 90 days horizon. Simply put, 13% of stocks are less volatile than Bioptik, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Bioptik Technology Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bioptik Technology's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Bioptik Technology, and traders can use it to determine the average amount a Bioptik Technology's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.031
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 4161 |
Estimated Market Risk
| 1.51 actual daily | 13 87% of assets are more volatile |
Expected Return
| -0.05 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Bioptik Technology is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bioptik Technology by adding Bioptik Technology to a well-diversified portfolio.
Bioptik Technology Fundamentals Growth
Bioptik Stock prices reflect investors' perceptions of the future prospects and financial health of Bioptik Technology, and Bioptik Technology fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bioptik Stock performance.
| Return On Equity | 0.0489 | |||
| Return On Asset | 0.0071 | |||
| Profit Margin | 0.05 % | |||
| Operating Margin | 0.02 % | |||
| Current Valuation | 1.83 B | |||
| Shares Outstanding | 48.27 M | |||
| Price To Book | 2.10 X | |||
| Price To Sales | 2.10 X | |||
| Revenue | 737.89 M | |||
| EBITDA | 64.41 M | |||
| Total Debt | 212.63 M | |||
| Book Value Per Share | 14.62 X | |||
| Cash Flow From Operations | (41.15 M) | |||
| Earnings Per Share | 0.77 X | |||
| Total Asset | 1.52 B | |||
About Bioptik Technology Performance
Evaluating Bioptik Technology's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Bioptik Technology has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Bioptik Technology has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Things to note about Bioptik Technology performance evaluation
Checking the ongoing alerts about Bioptik Technology for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Bioptik Technology help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Bioptik Technology generated a negative expected return over the last 90 days | |
| Bioptik Technology generates negative cash flow from operations | |
| About 24.0% of the company shares are owned by insiders or employees |
- Analyzing Bioptik Technology's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bioptik Technology's stock is overvalued or undervalued compared to its peers.
- Examining Bioptik Technology's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Bioptik Technology's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bioptik Technology's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Bioptik Technology's stock. These opinions can provide insight into Bioptik Technology's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Bioptik Stock Analysis
When running Bioptik Technology's price analysis, check to measure Bioptik Technology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioptik Technology is operating at the current time. Most of Bioptik Technology's value examination focuses on studying past and present price action to predict the probability of Bioptik Technology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioptik Technology's price. Additionally, you may evaluate how the addition of Bioptik Technology to your portfolios can decrease your overall portfolio volatility.